Related Experiment Video
Updated: Mar 24, 2026

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Therapy: A fine conception -- BSR/BHPR guidelines on drugs in pregnancy
Lisa R Sammaritano1, Bonnie L Bermas2
1Division of Rheumatology, Hospital for Special Surgery, 535 E. 70th Street, New York, New York 10021, USA.
Abstract:
Medical management of women with rheumatic diseases during pregnancy is challenging owing to incomplete information regarding medication safety. The British Society for Rheumatology and the British Health Professionals in Rheumatology committee published consensus guidelines that provide a good first step towards narrowing the knowledge gap in this important field.
More Related Videos
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
07:02Auricular Point Acupressure Therapy: A Safe and Effective Treatment for Postsurgical Abortion Recovery
Published on: February 3, 2026
Related Concept Videos
Teratogenicity
Factors Affecting Drug Response: Overview
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Intrauterine Drug Delivery Systems
Drug Regulation
Drug Classes and Categories